These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 32930122)
1. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association. Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122 [TBL] [Abstract][Full Text] [Related]
2. Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG. Hu F; Li C; Zheng X; Zhang H; Shen Y; Zhou L; Yang X; Han B; Zhang X Oncol Rep; 2020 Feb; 43(2):727-735. PubMed ID: 31894290 [TBL] [Abstract][Full Text] [Related]
3. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer. You L; Guo X; Huang Y Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma. Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762 [TBL] [Abstract][Full Text] [Related]
5. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells]. Yan ZY; Sun XC Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669 [No Abstract] [Full Text] [Related]
6. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4 Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related]
10. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions. Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866 [TBL] [Abstract][Full Text] [Related]
11. NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem Cells. Pitrone M; Pizzolanti G; Tomasello L; Coppola A; Morini L; Pantuso G; Ficarella R; Guarnotta V; Perrini S; Giorgino F; Giordano C Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545230 [TBL] [Abstract][Full Text] [Related]
12. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056 [TBL] [Abstract][Full Text] [Related]
13. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759 [TBL] [Abstract][Full Text] [Related]
14. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398 [TBL] [Abstract][Full Text] [Related]
15. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue. Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283 [TBL] [Abstract][Full Text] [Related]
16. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Li X; Wang J; Xu Z; Ahmad A; Li E; Wang Y; Qin S; Wang Q Int J Mol Sci; 2012; 13(6):7663-7675. PubMed ID: 22837720 [TBL] [Abstract][Full Text] [Related]
17. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals. Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes. Seo S; Jeon HY; Kim H DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914 [TBL] [Abstract][Full Text] [Related]
19. Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization. Sterlacci W; Savic S; Fiegl M; Obermann E; Tzankov A J Thorac Oncol; 2014 Jan; 9(1):41-9. PubMed ID: 24346092 [TBL] [Abstract][Full Text] [Related]